Avinoam Dayan, CEO
Avinoam brings to BrainsGate over 24 years of experience in leadership roles in various environments ranging from start-up companies to global conglomerates. Prior to joining BrainsGate Avinoam served as the CEO of Biosense Webster (Israel), after the acquisition by Johnson & Johnson. Avinoam holds an M.Sc in Science Management from the University of Polytechnic, Brooklyn, New York and a BA in Computer Science and Mathematics from the University of Haifa, Israel. |
Noam Levy, CFO
Noam brings to Brainsgate many years of experience as a senior management member in several companies. Prior to joining Brainsgate Noam co-founded and served as CEO of Paycard Ltd., an Internet payment service company. Before that Noam served as CFO of Itamar Medical Ltd., a medical device company. Noam holds an MBA from Stanford University and a B.Sc. in Aeronautical Engineering from the Technion-Israel Institute of Technology
|
Yoram Solberg MD, PhD., VP Medicine and Science
Yoram has extensive experience in the pre-clinical, clinical and business fields. Having graduated both his MD and PhD degrees Cum Laude from Ben-Gurion University, he has accumulated experience in neuroscience, and especially in the fields of molecular neuro-development and Neuroprotection. For the 6 years prior to joining BrainsGate, Yoram served as the founder and CEO of an Israeli software start-up company.
|
Hernan Altman, VP Stroke Application
A veteran of GE Healthcare Technologies, Hernan brings years of rich and diverse scientific and business experience to BrainsGate. Prior to joining the company, Hernan served as a senior manager in systems engineering, PET-CT program management, process improvement and quality control for GE Healthcare and ELGEMS (previously GE Medical Systems). Hernan holds an M.B.A., a B.Sc. in Industrial Engineering and a B.A. in Physics from the Technion-Israel Institute of Technology.
|
David Katz, VP Regulatory Affairs & QA
David brings with him nearly 15 years of professional experience in regulatory affairs, R&D and strategic planning of medical devices. Prior to joining BrainsGate, David was manager of regulatory affairs at the Israeli subsidiary of Elan Corporation, plc, a global neuroscience based biotechnology company. He also held an R&D position with Cordis Corporation, a US based medical device subsidiary of Johnson & Johnson. David has a B.Sc. degree in Mechanical Engineering (B.S.M.E.) from Florida International University (F.I.U.) and is a registered member of the Israeli Federation of Graduate Engineers.
|
Raveh Gill-More, VP Business Development
Raveh brings with him an impressive record in business development and marketing in the high-tech and biotech sectors. Prior to joining BrainsGate, Raveh held senior marketing and business development positions in several companies including Metalink Broadband (Nasdaq: MTLK), and Compugen (Nasdaq: CGEN). Raveh holds an M.B.A. from Heriot-Watt University, Edinburgh, an M.Sc. in pure math, and a B.Sc. in math and physics from the Tel Aviv University. |
|
November 17, 2009
Investigational neurostimulation device aims to reduce stroke damage
Stroke researchers at the Methodist Neurological Institute in Houston are the only ones in Texas to offer a novel device that might extend the acute stroke treatment window from three hours to 24 (PhysOrg.com)
> full story
October 13, 2009
ImpACT-24 at Central DuPage Hosital
National Investigational Trial for Emergency Stroke Care At CDH: One Illinois Hospital Tests New Device That May Reverse Brain Damage Up to 24 Hours After Stroke > full story
|
Login
